List of insiders holdings for Olema Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences IV General Partner LLC Bain Capital Life Sciences Fund IV L.P. Bain Capital Life Sciences Opportunities IV GP LLC Bain Capital Life Sciences Opportunities IV L.P. 10% Owner |
2025-01-13 16:34:40 | 0 11,300,000 |
11,300,000 | Form 4 |
| 2 | Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner |
2025-02-14 16:45:39 | 7,429,355 0 |
7,429,355 | Form 13G |
| 3 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses |
2025-01-14 18:38:56 | 6,602,852 251,676 |
6,854,528 | Form 4 |
| 4 | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner |
2024-02-14 15:08:09 | 2,456,800 0 |
2,456,800 | Form 13G |
| 5 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
2020-11-24 17:36:39 | 1,725,406 0 |
1,725,406 | Form 4 |
| 6 | Graham G. Walmsley Director |
2024-12-18 18:52:04 | 0 1,408,875 |
1,408,875 | Form 4/A |
| 7 | Harmon Cyrus Director |
2024-12-11 19:56:44 | 764,140 122,028 |
886,168 | Form 4 |
| 8 | Bohen Sean PRESIDENT AND CEO |
2025-03-03 16:15:14 | 650,000 0 |
650,000 | Form 4 |
| 9 | Mitchell Shawnte CHIEF LEGAL OFFICER |
2025-03-03 16:18:17 | 450,000 0 |
450,000 | Form 4 |
| 10 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. |
2025-03-03 16:16:48 | 320,000 0 |
320,000 | Form 4 |
| 11 | MCCORMICK FRANK Director |
2020-11-23 16:33:24 | 191,113 84,260 |
275,373 | Form 4 |
| 12 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF |
2025-03-03 16:20:52 | 205,000 0 |
205,000 | Form 4 |
| 13 | Zojwalla Naseem CHIEF MEDICAL OFFICER |
2025-03-03 16:19:32 | 205,000 0 |
205,000 | Form 4 |
| 14 | Moriarty John B EVP, Ch. Legal Officer & Sec. |
2023-02-02 17:34:20 | 150,000 0 |
150,000 | Form 4 |
| 15 | Horn Kinney Chief Business Officer |
2023-02-02 17:30:22 | 150,000 0 |
150,000 | Form 4 |
| 16 | Kushner Peter J. CHIEF SCIENTIFIC OFFICER |
2022-02-03 19:12:25 | 61,750 0 |
61,750 | Form 4 |
| 17 | Horning Sandra Director |
2024-06-18 17:00:25 | 23,000 0 |
23,000 | Form 4 |
| 18 | RAPPAPORT ANDREW Director |
2024-06-18 17:00:23 | 23,000 0 |
23,000 | Form 4 |
| 19 | Larson Yi Director |
2024-06-18 17:00:21 | 23,000 0 |
23,000 | Form 4 |
| 20 | Hrustanovic Gorjan Director |
2024-06-18 17:00:17 | 23,000 0 |
23,000 | Form 4 |
| 21 | CLARK IAN T Director |
2024-06-18 17:00:16 | 23,000 0 |
23,000 | Form 4 |
| 22 | Garland J. Scott Director |
2024-06-18 17:00:15 | 23,000 0 |
23,000 | Form 4 |
| 23 | BUTITTA CYNTHIA M Director |
2024-06-18 17:00:10 | 23,000 0 |
23,000 | Form 4 |